The need for new therapeutic approaches in visceral leishmaniasis during HIV infection.

Por Lafeuillade, A., Quilichini, R., Dhiver, C., Mary, C., Gastaut, J. A.
Publicado em 1990

Intestinal spirochaetosis in HIV infected homosexual men.

Por Lafeuillade, A., Quilichini, R., Benderitter, T., Delbeke, E., Dhiver, C., Gastaut, J. A.
Publicado em 1990

Efficacy and safety of hepatitis C direct-acting protease inhibitors (DAA-PI ) in real life in HIV-HCV coinfected patients

Por Ménard, A, Dhiver, C, Ravaux, I, Moreau, J, Mokhtari, S, Colson, P, Meddeb, L, Brouqui, P, Stein, A
Publicado no BMC Infect Dis (2014)

Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevi...

Por Chantry, AS, Tching-Sin, M, Dhiver, C, Allegre, T, Ruiz, JM, Assi, A, Botta-Fridlund, D, Halfon, P, Faucher-Zaegel, O, Solas, C
Publicado no BMC Infect Dis (2014)